HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short course of albendazole therapy for neurocysticercosis.

Abstract
Albendazole is now used for therapy of neurocysticercosis; however, duration of treatment has usually been empirically determined. In this study we shortened the length of therapy from one month in previous reports, to one week. Twelve patients with parenchymal brain cysticercosis were treated with albendazole for eight days at daily doses of 15 mg/kg of body weight. After three months of treatment the number of cysts on computed tomography had decreased from 185 to six; a 97% reduction in the number of lesions. Total remission of all cysts was seen in nine patients. Two cases had been unsuccessfully treated before with praziquantel, in both instances albendazole therapy was effective with 100% improvement. Our results indicated that a short course of albendazole is highly effective for treatment of neurocysticercosis.
AuthorsJ Sotelo, P Penagos, F Escobedo, O H Del Brutto
JournalArchives of neurology (Arch Neurol) Vol. 45 Issue 10 Pg. 1130-3 (Oct 1988) ISSN: 0003-9942 [Print] United States
PMID3178533 (Publication Type: Journal Article)
Chemical References
  • Anthelmintics
  • Benzimidazoles
  • Albendazole
Topics
  • Adult
  • Albendazole
  • Anthelmintics (therapeutic use)
  • Benzimidazoles (adverse effects, therapeutic use)
  • Brain (microbiology, pathology)
  • Brain Diseases (diagnosis, diagnostic imaging, drug therapy)
  • Cysticercosis (diagnosis, diagnostic imaging, drug therapy)
  • Female
  • Hemianopsia (etiology)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Seizures (etiology)
  • Time Factors
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: